How does the New CMS GLP-1 CMS Bridge Program Work?

The Medicare GLP-1 Bridge program is a temporary federal demonstration initiative by the Centers for Medicare & Medicaid Services (CMS) that launched on July 1, 2026, and runs through December 31, 2027.

The New CMS GLP-1 CMS Bridge Program Works

The program circumvents standard Medicare Part D rules to provide flat-fee access to weight-loss medications for eligible seniors who otherwise could not afford them.

How the Program Works

• The Cost: Eligible beneficiaries pay a predictable, flat copay of $50 per month for covered medications.
• Outside of Part D: The program operates independently of standard Medicare Part D plans. As a result, your $50 copay does not count toward your Part D annual deductible or true out-of-pocket spending limits.
• Central Processor: CMS has contracted Humana to act as the central administrator. Humana handles all prior authorizations, claim approvals, and pharmacy payments completely separately from your day-to-day insurance plan.

Covered Medications

The program specifically covers three anti-obesity GLP-1 medications when prescribed strictly for weight reduction and maintenance:

• Wegovy® (both injectable and tablet formulations)
• Zepbound® (KwikPen® formulation only; single-dose vials or standard single-dose pens are not covered)
• Foundayo® (tablet)

Who is Eligible?

To qualify for the $50/month bridge pricing, you must meet all of the following criteria:

1. Plan Status: You must be enrolled in a Medicare Part D standalone prescription plan or a Medicare Advantage plan that includes drug coverage.
2. No Existing Coverage: You are not eligible if you already receive a GLP-1 drug covered by your Part D plan, or if your plan already offers a pathway to cover it.
3. Exclusion Criteria: You must not have Type 2 diabetes, moderate-to-severe sleep apnea, or fatty liver disease. (If you have these conditions, you are excluded because you should already qualify for standard Part D coverage pathways for these drugs).
4. Clinical/BMI Thresholds: You must be at least 18 years old and meet specific Body Mass Index (BMI) tiers based on your health history at the time you started therapy:
   • BMI of 35 or higher: Qualifies automatically.
   • BMI of 30 to 34.9: Qualifies if you also have heart failure (HFpEF), uncontrolled high blood pressure, or chronic kidney disease.
   • BMI of 27 to 29.9: Qualifies if you have prediabetes or a history of a heart attack, stroke, or blocked arteries in your extremities.

How to Get Started

1. See Your Doctor: Your provider must prescribe one of the covered formulations listed above.
2. Pharmacy Submission: When the pharmacy processes the prescription, they will encounter a block and automatically generate an electronic prior authorization (ePA) request to your doctor.
3. Doctor Attestation: Your doctor fills out the Medicare Bridge prior authorization form, attesting to your clinical eligibility and BMI history.
4. Approval: Once the central processor approves it, you will receive an approval letter and can pick up your 28- or 30-day supply for $50.

Credible Sources & Links

• Official CMS Press Announcement: Read the official program launch details on the CMS Newsroom.
• Official Patient Guide & Fact Sheet: Download the clear, official PDF breakdown on Medicare.gov.
• Medicare Coverage Requirements Page: Review the consumer-facing coverage parameters directly on the Medicare.gov Weight Loss Drugs Page.
• Official Guidance for Prescribers: Review the deep technical requirements and PDF form guidelines at the CMS Provider Portal.
• KFF (Kaiser Family Foundation) Independent Analysis: See the independent research data on how many millions qualify and what the program will cost the government at KFF.org.